Abeona Therapeutics plans $75 million at-the-market offering of stock

Agents FBR, JonesTrading, Maxim help fund general corporate purposes

By Devika Patel

Knoxville, Tenn., Aug. 26 – Abeona Therapeutics Inc. negotiated a $75 million at-the-market equity offering with agents FBR Capital Markets & Co., JonesTrading Institutional Services LLC and Maxim Group LLC on Aug. 26, according to an 8-K and prospectus supplement filed Friday with the Securities and Exchange Commission.

The agents will be paid a 3% commission.

Proceeds will be used for working capital and general corporate purposes.

Based in New York, Abeona develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.